 |
Cancer of the Ovary - General
|
|||||||||||||||||||
                
|
Contents
FIGO (1988) STAGING (1)Staging is based on surgicopathological findings. Stage I:-
Stage IA Growth limited to one ovary; no ascites; no tumour on the external surface; capsule intact. Stage IB Growth limited to both ovaries; no ascites; no tumour on the external surface; capsule intact. Stage IC* Tumour either stage IA or IB, but with tumour on the surface of one or both ovaries; or with capsule ruptured ; or with ascites present containing malignant cells or with positive peritoneal washings Stage II:-
Stage IIA Extension and/or metastases to the uterus and/or tubes Stage IIB Extension to other pelvic tissues Stage IIC* Tumour either stage IIA or IIB, but with tumour on the surface of one or both ovaries; or with capsule(s) ruptured ; or with ascites present containing malignant cells or with positive peritoneal washings Stage III:-
Stage IIIA Tumour grossly limited to the true pelvis with negative nodes but with histologically confirmed seeding of the abdominal peritoneal surfaces Stage IIIB Tumour involving one or both ovaries with histologically confirmed implants or abdominal peritoneal surfaces none exceeding 2 cm in diameter. Nodes are negative Stage IIIC Abdominal implants greater than 2 cm in diameter and/or positive retroperitoneal or inguinal nodes Stage IV:-
* In order to evaluate the impact on prognosis of the different criteria for allotting cases to stage IC or IIC it would be of value to know if the source of malignant cells detected was peritoneal washings or ascites, and if rupture of the capsule was spontaneous or caused by the surgeon. Dr James L. Nicklin
|
Email
us
|
